CLASS II ONGOING Drug recall · Reported 4 Nov 2026 · FDA Enforcement Report

Atorvastatin Calcium Tablets, USP, 40mg recalled

MSN Laboratories Private Limited (Formulations Division, Unit-II) is recalling Atorvastatin Calcium Tablets, USP, 40mg per, distributed nationwide in the US. The recall was initiated on 21 Oct 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot: DRF09618A, Exp 08-31-2029, DRG02110A, Exp 01-31-2030.
NDC72205-022, 72205-023, 72205-024, 72205-025
UPC0372205025905, 0372205025059, 0372205024052
Quantity recalled13,296 1,000-count bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0113-2027
FDA event ID
100172
Manufacturer
Novadoz Pharmaceuticals LLC
Classification
Class II
Status
Ongoing
Recall initiated
21 Oct 2026
FDA classified
29 Oct 2026
Reported
4 Nov 2026
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

21 Oct 2026Recall initiated by company
29 Oct 2026Classified by FDA+8 days
4 Nov 2026Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of Foreign Tablets/Capsules

Product as listed by the FDA

Atorvastatin Calcium Tablets, USP, 40mg, 1000 tablets per bottle, Rx only, Manufactured by: MSL Laboratories Private Limited, Telangana - 509228, India; Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854-3714. NDC: 72205-024-99

Where it was distributed

Nationwide in the USA.

Nationwide

Questions about this recall

Why was it recalled?

Presence of Foreign Tablets/Capsules

Which lots are affected?

Lot: DRF09618A, Exp 08-31-2029, DRG02110A, Exp 01-31-2030.

Where was it sold?

Nationwide in the USA.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 10 Nov 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other Atorvastatin recalls

All 47